In this Oct 10, 2018 photo, a staff member managing drugs at the pharmacy of the second affiliated hospital of Zhejiang University School of Medicine in Hangzhou, east China's Zhejiang province. (HUANG ZONGZHI / XINHUA)
BEIJING – China will further shorten the time required for the registration and approval of new cancer drugs and cut prices, a State Council executive meeting chaired by Premier Li Keqiang decided on Monday.
It was decided at a State Council executive meeting that China will step up efforts to ensure more early diagnosis and treatment of cancer
Experts will be gathered to select overseas new drugs to meet urgent clinical needs, while import policies will be improved for faster launch of the drugs in China, according to a statement released after the meeting.
READ MORE: Hospitals get access to new cancer drugs
The country will step up efforts to ensure more early diagnosis and treatment of cancer, and offer preferential value added tax policies for drugs for treatment of rare diseases.
It was also decided at the meeting that China will enhance its anti-poverty efforts to lift at least 10 million people out of poverty in 2019 after bringing 13.86 million people out of poverty last year.
China will support commercial banks to replenish capital through various channels including speeding up approval of perpetual bond issuance and introducing long-term investors.
This Oct 10, 2018 photo shows an anti-cancer drug which is newly included in the government's basic medical insurance programs in Hangzhou, east China's Zhejiang province. (HUANG ZONGZHI / XINHUA)
Lenders with augmented capital are required to offer more loans to private enterprises and small and micro businesses, according to the meeting.
Copyright 1995 - 2019. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily. Without written authorization from China Daily, such content shall not be republished or used in any form.
HONG KONG NEWS